CD-precise discrete dose form (clinical drug) - in progress

Descriptions:

Term	description type	Language/acceptability	Language/acceptability	Case significance
Product containing precisely [substance][number][Unit of measure ]/[1] each [dose form] (clinical drug)	FSN	us:P	gb:P	ci
[substance] [Unit of measure ] [dose form]	SYN	us:P	gb:P	ci

Attribute cardinality	Attribute	Value	role group number	role group cardinality
	116680003 \|Is a (attribute)\|	3763158003 \|Medicinal product (product)\|	0	N/A
1..1	411116001 \|Has manufactured dose form (attribute)\|	< 736542009 \|Pharmaceutical dose form (dose form)\|	0	1..1
1..1	763032000 \|Has unit of presentation (attribute)\|	< 732935002 \|Unit of presentation (unit of presentation)\|	0	1..1
1..1	766952006 \|Count of base of active ingredient (attribute)\|	< 260299005 \|Number (qualifier value)\|	0	1..1
0..1	766954007 \|Count of base and modification pair (attribute)\|	< 260299005 \|Number (qualifier value)\|	0	0..1
0..1	766953001 \|Count of active ingredient (attribute)\|	< 260299005 \|Number (qualifier value)\|	0	0..1
1..1	762949000 \|Has precise active ingredient (attribute)\|	< 105590001 \|Substance (substance)\|	1..*	1..*
1..1	732943007 \|Has basis of strength substance (attribute)\|	< 105590001 \|Substance (substance)\|	1..*
1..1	732944001 \|Has presentation strength numerator value (attribute)\|	< 260299005 \|Number (qualifier value)\|	1..*
1..1	732945000 \|Has presentation strength numerator unit (attribute)\|	< 767524001 \|Unit of measure (qualifier value)\|	1..*
1..1	732946004 \|Has presentation strength denominator value (attribute)\|	38112003 \|1 (qualifier value)\|	1..*
0..1	732947008 \|Has presentation strength denominator unit (attribute)\|	732935002 \|Unit of presentation (unit of presentation)\|	1..*

Apply General rules for generating descriptions for templates
Exceptions:Concepts with product strength that is "not equal to" (e.g. with product strength expressed as a range, greater than, or less than) will have definition status 900000000000074008| Primitive (core metadata concept) and will have the appropriate Medicinal Product Form-only (MPF-only) concept as a stated parent.
For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).

DRUGS-276 - Getting issue details... STATUS